Skip to content

PEG ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.2×
Merck & Co. logo
Merck & Co.MRK
2.2×
Incyte logo
IncyteINCY
Gilead Sciences logo
Gilead SciencesGILD
0.3×+0.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
Amgen logo
AmgenAMGN
0.8×+0.3×

Other financials

Income statement

See full
Revenue$11.5B+2.6%
Gross profit$8.1B-1.2%
Net income$2.7B+9.0%
EPS (diluted)$1.31+9.2%

Balance sheet

See full
Cash & equivalents$9.6B-12.0%
Total debt$44.7B-10.5%
Total equity$20.1B+15.4%
Total assets$86.5B-6.4%

Cash flow

See full
Operating cash flow$1.1B-43.5%
CapEx$347.0M+33.5%
Free cash flow$757.0M-55.3%

Valuation

See full
Market cap$112.89B-0.2%
Enterprise value$147.97B-2.6%
P/E15.5×-5.6×
P/S2.3×0.0×

Profitability

See full
Gross margin70.5%0.0pp
Net margin15%+3.8pp

Returns & leverage

See full
Return on equity38.8%+7.3pp
Debt / equity2.2×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Calculated from Bristol-Myers Squibb’s reported figures.

Based on the most recent quarter.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bristol-Myers Squibb's PEG ratio?
Bristol-Myers Squibb (BMY) reported PEG ratio of 0.5× in Q1 2026.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.